220 related articles for article (PubMed ID: 34884678)
21. Is melatonin, leptin or their combination more effective on oxidative stress and folliculogenesis in the obese rats?
Tümentemur G; Altunkaynak BZ; Kaplan S
J Obstet Gynaecol; 2020 Jan; 40(1):116-127. PubMed ID: 31625776
[TBL] [Abstract][Full Text] [Related]
22. The BRCA1 Methylation and PD-L1 Expression in Sporadic Ovarian Cancer.
Zhu X; Zhao L; Lang J
Int J Gynecol Cancer; 2018 Oct; 28(8):1514-1519. PubMed ID: 30045136
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer.
Tian X; Han Y; Yu L; Luo B; Hu Z; Li X; Yang Z; Wang X; Huang W; Wang H; Zhang Q; Ma D
Cancer Biol Ther; 2017 Apr; 18(4):245-251. PubMed ID: 28346042
[TBL] [Abstract][Full Text] [Related]
24. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.
Schmid G; Notaro S; Reimer D; Abdel-Azim S; Duggan-Peer M; Holly J; Fiegl H; Rössler J; Wiedemair A; Concin N; Altevogt P; Marth C; Zeimet AG
BMC Cancer; 2016 Feb; 16():102. PubMed ID: 26879132
[TBL] [Abstract][Full Text] [Related]
25. Aberrant expression of ADAM9 in ovarian cancer and its clinical significance.
Guo T; Yuan D; Lin M; Zhu D; Xu N; Wang J
J Clin Lab Anal; 2020 Apr; 34(4):e23136. PubMed ID: 31793719
[TBL] [Abstract][Full Text] [Related]
26. BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.
Kalachand RD; Stordal B; Madden S; Chandler B; Cunningham J; Goode EL; Ruscito I; Braicu EI; Sehouli J; Ignatov A; Yu H; Katsaros D; Mills GB; Lu KH; Carey MS; Timms KM; Kupryjanczyk J; Rzepecka IK; Podgorska A; McAlpine JN; Swisher EM; Bernards SS; O'Riain C; O'Toole S; O'Leary JJ; Bowtell DD; Thomas DM; Prieske K; Joosse SA; Woelber L; Chaudhry P; Häfner N; Runnebaum IB; Hennessy BT
J Natl Cancer Inst; 2020 Dec; 112(12):1190-1203. PubMed ID: 32413141
[TBL] [Abstract][Full Text] [Related]
27. Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer.
Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF
Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.
Kirn V; Shi R; Heublein S; Knabl J; Guenthner-Biller M; Andergassen U; Fridrich C; Malter W; Harder J; Friese K; Mayr D; Jeschke U
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1681-7. PubMed ID: 24908329
[TBL] [Abstract][Full Text] [Related]
29. Construction and Analysis of an Adipose Tissue-Specific and Methylation-Sensitive Promoter of Leptin Gene.
Zhang Q; Xu D; Zhang M; Dong X; Dong H; Pan Q
Appl Biochem Biotechnol; 2016 Nov; 180(6):1213-1226. PubMed ID: 27299919
[TBL] [Abstract][Full Text] [Related]
30. REDD1 and p-AKT over-expression may predict poor prognosis in ovarian cancer.
Jia W; Chang B; Sun L; Zhu H; Pang L; Tao L; Zou H; Du J; Dong Y; Qi Y; Jiang J; Liang W; Li F; Zhao X
Int J Clin Exp Pathol; 2014; 7(9):5940-9. PubMed ID: 25337238
[TBL] [Abstract][Full Text] [Related]
31. Placental leptin gene methylation and macrosomia during normal pregnancy.
Xu X; Yang X; Liu Z; Wu K; Liu Z; Lin C; Wang Y; Yan H
Mol Med Rep; 2014 Mar; 9(3):1013-8. PubMed ID: 24452268
[TBL] [Abstract][Full Text] [Related]
32. LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA).
Jin TY; Saindane M; Park KS; Kim S; Nam S; Yoo Y; Yang JH; Yun I
Medicine (Baltimore); 2021 Aug; 100(33):e26896. PubMed ID: 34414945
[TBL] [Abstract][Full Text] [Related]
33. ATP binding cassette subfamily B member 9 (ABCB9) is a prognostic indicator of overall survival in ovarian cancer.
Hou L; Zhang X; Jiao Y; Li Y; Zhao Y; Guan Y; Liu Z
Medicine (Baltimore); 2019 May; 98(19):e15698. PubMed ID: 31083274
[TBL] [Abstract][Full Text] [Related]
34. Assessment of prognostic value of tissue inhibitors of metalloproteinase 3 (TIMP3) protein in ovarian cancer.
Hakamy S; Assidi M; Jafri MA; Nedjadi T; Alkhatabi H; Al-Qahtani A; Al-Maghrabi J; Sait K; Al-Qahtani M; Buhmeida A; Chaudhary A
Libyan J Med; 2021 Dec; 16(1):1937866. PubMed ID: 34240668
[No Abstract] [Full Text] [Related]
35. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
Kikuchi R; Tsuda H; Kozaki K; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
Cancer Res; 2008 Jul; 68(13):5067-75. PubMed ID: 18593905
[TBL] [Abstract][Full Text] [Related]
36. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.
Zhou F; Tao G; Chen X; Xie W; Liu M; Cao X
Clin Chem Lab Med; 2014 May; 52(5):735-42. PubMed ID: 24327526
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.
Shu J; Xiao L; Yan S; Fan B; Zou X; Yang J
Technol Cancer Res Treat; 2021; 20():1533033820980115. PubMed ID: 33928819
[TBL] [Abstract][Full Text] [Related]
38. Methylation of the LEP gene promoter in blood at 12 months and BMI at 4 years of age-a population-based cohort study.
Mansell T; Ponsonby AL; Collier F; Burgner D; Pezic A; Vuillermin P; Ryan J; Saffery R;
Int J Obes (Lond); 2020 Apr; 44(4):842-847. PubMed ID: 32107462
[TBL] [Abstract][Full Text] [Related]
39. Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia.
Xiang Y; Cheng Y; Li X; Li Q; Xu J; Zhang J; Liu Y; Xing Q; Wang L; He L; Zhao X
PLoS One; 2013; 8(3):e59753. PubMed ID: 23544093
[TBL] [Abstract][Full Text] [Related]
40. Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia.
Zhang TJ; Xu ZJ; Gu Y; Ma JC; Wen XM; Zhang W; Deng ZQ; Qian J; Lin J; Zhou JD
Clin Epigenetics; 2021 Jan; 13(1):16. PubMed ID: 33485366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]